Skip to main content
Log in

Renal denervation for resistant hypertension: no

  • DEBATE
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

In recent years, catheter-based radiofrequency denervation of the renal arteries (RDN) has emerged as a potential treatment for resistant hypertension. Though initial non-randomized and randomized small studies demonstrate large reductions in office blood pressure, RDN superiority to conventional treatment is not confirmed either by randomized controlled trials or by large international registries. Increasing evidence supports the hypothesis that a rational pharmacological therapeutic scheme is equally or more effective; this approach, together with an intervention aimed at increasing patient’s compliance with treatment, might solve most of the cases of refractory hypertension. Thus, based on current evidence, renal denervation should not be routinely used to treat resistant hypertension. Though the possibility that RDN might be useful in other subsets of hypertensive patients exists, it has never been proven. Thus, its use should be limited to extreme situations, when all other possible treatments have failed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, Investigators SH- (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393–1401. doi:10.1056/NEJMoa1402670

    Article  CAS  PubMed  Google Scholar 

  2. Bruno RM, Di Giulio A, Bernini G, Virdis A, Ghiadoni L, Taddei S (2013) Device-based therapies for resistant hypertension. Curr Pharm Des 19(13):2401–2408

    Article  CAS  PubMed  Google Scholar 

  3. Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, Francis DP, di Mario C (2015) Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation. Hypertension 65(2):401–406. doi:10.1161/HYPERTENSIONAHA.114.04640

    Article  CAS  PubMed  Google Scholar 

  4. Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O’Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL (2015) Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J 36(4):219–227. doi:10.1093/eurheartj/ehu441

    Article  PubMed  PubMed Central  Google Scholar 

  5. Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Vehier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G, Renal Denervation for Hypertension Investigators (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385(9981):1957–1965. doi:10.1016/S0140-6736(14)61942-5

    Article  PubMed  Google Scholar 

  6. Booth LC, Nishi EE, Yao ST, Ramchandra R, Lambert GW, Schlaich MP, May CN (2015) Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension 65(2):393–400. doi:10.1161/HYPERTENSIONAHA.114.04176

    Article  CAS  PubMed  Google Scholar 

  7. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc

    Article  CAS  PubMed  Google Scholar 

  8. Barbato A, Galletti F, Iacone R, Cappuccio FP, Rossi G, Ippolito R, Venezia A, Farinaro E, Strazzullo P (2012) Predictors of resistant hypertension in a unselected sample of an adult male population in Italy. Intern Emerg Med 7(4):343–351

    Article  PubMed  Google Scholar 

  9. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR, Black HR, Service RUH (2005) Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 18(5 Pt 1):619–626. doi:10.1016/j.amjhyper.2004.11.021

    Article  PubMed  Google Scholar 

  10. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57(5):898–902. doi:10.1161/HYPERTENSIONAHA.110.168948

    Article  PubMed  Google Scholar 

  11. Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, Samani NJ, Gupta P, Madira W, Stanley A, Williams B (2014) High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography–tandem mass spectrometry (HP LC–MS/MS) urine analysis. Heart 100(11):855–861. doi:10.1136/heartjnl-2013-305063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fadl Elmula FE, Rebora P, Talvik A, Salerno S, Miszkowska-Nagorna E, Liu X, Heinpalu-Kuum M, Comotti T, Larstorp AC, Rostrup M, Swierblewska E, Valsecchi MG, Kjeldsen SE, Viigimaa M, Narkiewicz K, Parati G, Laurent S, Investigators BEcobpihpmUtHsS (2015) A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients. J Hypertens 33(12):2534–2545. doi:10.1097/HJH.0000000000000749

    Article  CAS  PubMed  Google Scholar 

  13. Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, Das SR, Halm EA, Kaplan NM, Vongpatanasin W (2014) Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. J Am Coll Cardiol 63(8):834–835. doi:10.1016/j.jacc.2013.10.067

    Article  PubMed  PubMed Central  Google Scholar 

  14. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA (2009) Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 54(3):475–481. doi:10.1161/HYPERTENSIONAHA.109.131235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371(9628):1921–1926

    Article  CAS  PubMed  Google Scholar 

  16. Vaclavik J, Sedlak R, Plachy M, Navratil K, Plasek J, Jarkovsky J, Vaclavik T, Husar R, Kocianova E, Taborsky M (2011) Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension 57(6):1069–1075. doi:10.1161/HYPERTENSIONAHA.111.169961

    Article  CAS  PubMed  Google Scholar 

  17. Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ, British Hypertension Society’s PSG (2015) Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. doi:10.1016/S0140-6736(15)00257-3

    Google Scholar 

  18. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58(5):811–817. doi:10.1161/HYPERTENSIONAHA.111.179788

    Article  CAS  PubMed  Google Scholar 

  19. Bruno RM, Palagini L, Gemignani A, Virdis A, Di Giulio A, Ghiadoni L, Riemann D, Taddei S (2013) Poor sleep quality and resistant hypertension. Sleep Med 14(11):1157–1163. doi:10.1016/j.sleep.2013.04.020

    Article  PubMed  Google Scholar 

  20. Varounis C, Katsi V, Kallikazaros IE, Tousoulis D, Stefanadis C, Parissis J, Lekakis J, Siristatidis C, Manolis AJ, Makris T (2014) Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J Cardiol 175(1):195–198. doi:10.1016/j.ijcard.2014.04.240

    Article  PubMed  Google Scholar 

  21. Grassi G, Bombelli M, Buzzi S, Volpe M, Brambilla G (2014) Neuroadrenergic disarray in pseudo-resistant and resistant hypertension. Hypertens Res 37(6):479–483. doi:10.1038/hr.2014.25

    Article  CAS  PubMed  Google Scholar 

  22. Sudano I, Noll G, Luscher TF (2013) Potential new indications and future studies. Eurointervention 9 Suppl R:R155–R160. doi:10.4244/EIJV9SRA26

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Taddei.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taddei, S., Dal Canto, E. & Bruno, R.M. Renal denervation for resistant hypertension: no. Intern Emerg Med 11, 495–498 (2016). https://doi.org/10.1007/s11739-016-1428-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-016-1428-4

Keywords

Navigation